Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 22, 2019
Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break
Geoffrey L Rogers, Hsu-Yu Chen, Heidy Morales, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 19, 2019
Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors"
Geoffrey L Rogers, Hsu-Yu Chen, Heidy Morales, et al.
Molecular Therapy. Methods & Clinical Development
|
October 27, 2021
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes
Geoffrey L Rogers, Chun Huang, Robert D E Clark, et al.
Journal of Virology
|
August 9, 2023
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides
George N Llewellyn, Hsu-Yu Chen, Geoffrey L Rogers, et al.
Heliyon
|
February 21, 2025
Performance comparison between the conventional and blade-designed two-fluid pressure nozzles via CFD simulation
Che-Hao Hsu, Hong-Ping Cheng, Yu-Cheng Chou, et al.
Expert Opinion on Drug Safety
|
August 23, 2022
Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis
John Hang Leung, Yun-Sheng Tai, Shyh-Yau Wang, et al.
Cells
|
May 16, 2023
SARS-CoV-2 Enters Human Leydig Cells and Affects Testosterone Production In Vitro
Lu Li, Chantal M Sottas, Hsu-Yu Chen, et al.
Research Square
|
July 28, 2023
Reprogramming human B cells with custom heavy chain antibodies
Geoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Nature Biomedical Engineering
|
July 22, 2024
Reprogramming human B cells with custom heavy-chain antibodies
Geoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Reprogramming human B cells with custom heavy chain antibodies
Geoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 22, 2019
Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break
Geoffrey L Rogers, Hsu-Yu Chen, Heidy Morales, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 19, 2019
Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors"
Geoffrey L Rogers, Hsu-Yu Chen, Heidy Morales, et al.
Molecular Therapy. Methods & Clinical Development
|
October 27, 2021
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes
Geoffrey L Rogers, Chun Huang, Robert D E Clark, et al.
Journal of Virology
|
August 9, 2023
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides
George N Llewellyn, Hsu-Yu Chen, Geoffrey L Rogers, et al.
Heliyon
|
February 21, 2025
Performance comparison between the conventional and blade-designed two-fluid pressure nozzles via CFD simulation
Che-Hao Hsu, Hong-Ping Cheng, Yu-Cheng Chou, et al.
Expert Opinion on Drug Safety
|
August 23, 2022
Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis
John Hang Leung, Yun-Sheng Tai, Shyh-Yau Wang, et al.
Cells
|
May 16, 2023
SARS-CoV-2 Enters Human Leydig Cells and Affects Testosterone Production In Vitro
Lu Li, Chantal M Sottas, Hsu-Yu Chen, et al.
Research Square
|
July 28, 2023
Reprogramming human B cells with custom heavy chain antibodies
Geoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Nature Biomedical Engineering
|
July 22, 2024
Reprogramming human B cells with custom heavy-chain antibodies
Geoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Reprogramming human B cells with custom heavy chain antibodies
Geoffrey L Rogers, Chun Huang, Atishay Mathur, et al.
Page
of 2